A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies - Join Clinical Trial NCTNCT05081609
How to Join This Clinical Trial - NCTNCT05081609
Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1, PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05081609 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 69 locations. Find a study site near you:
Clinical Research Site
Los Angeles, California 90048 - United States
Status: RECRUITING
Clinical Research Site
Los Angeles, California 90067 - United States
Status: RECRUITING
Clinical Research Site
Springfield, Illinois 62702 - United States
Status: RECRUITING
Clinical Research Site
Louisville, Kentucky 40202 - United States
Status: RECRUITING
Clinical Research Site
Boston, Massachusetts 02114 - United States
Status: RECRUITING
Clinical Research Site
Morristown, New Jersey 07960 - United States
Status: RECRUITING
Clinical Research Site
New York, New York 10032 - United States
Status: RECRUITING
Clinical Research Site
Huntersville, North Carolina 28078 - United States
Status: TERMINATED
Clinical Research Site
Canton, Ohio 44718 - United States
Status: RECRUITING
Clinical Research Site
Cincinnati, Ohio 45219 - United States
Status: RECRUITING
And 59 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE1, PHASE2 clinical trial for Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai as Your Clinical Trial Matching Service
Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:
- Find clinical trials that match your condition
- Get matched to the right study location near you
- Connect directly with study coordinators
- Understand if you qualify with simplified eligibility screening
- Navigate the enrollment process with personalized support
- Access new treatments through clinical research participation